Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but is still on course for a major defeat by failing to stop a bill that
By Ahmed Aboulenein WASHINGTON (Reuters) - Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters a.
Big Pharma spent more than any other industry to lobby Congress and federal agencies this year, a Reuters analysis shows, but is still on course for a major
After a record-breaking year of lobbying, Big Pharma walks away empty-handed as the Senate passes a bill allowing the U.S. government to negotiate drug prices.
Senate drug price bill is limited to Medicare Here s what it means for those with private insurance localnews8.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from localnews8.com Daily Mail and Mail on Sunday newspapers.